Veracyte Announces First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Caterpillar names Derrick York to lead Resource Industries
- Intel shares drop on foundry risks, sector pressures
Veracyte (VCYT) Tops Q1 EPS by 3c, Reiterates FY Outlook
May 14, 2015 4:28 PM EDTVeracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.34), $0.03 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $10.83 million.
2015 Financial Outlook
Veracyte reiterates its 2015 annual revenue guidance of $48 million to $53 million, as well... More



